Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
Add more filters










Publication year range
1.
Mini Rev Med Chem ; 17(1): 62-77, 2017.
Article in English | MEDLINE | ID: mdl-27342232
2.
Br J Nutr ; 112(6): 886-99, 2014 Sep 28.
Article in English | MEDLINE | ID: mdl-25201301

ABSTRACT

Black bean (Phaseolus vulgaris L.) seed coats are a rich source of natural compounds with potential beneficial effects on human health. Beans exert hypolipidaemic activity; however, this effect has not been attributed to any particular component, and the underlying mechanisms of action and protein targets remain unknown. The aim of the present study was to identify and quantify primary saponins and flavonoids extracted from black bean seed coats, and to study their effects on lipid metabolism in primary rat hepatocytes and C57BL/6 mice. The methanol extract of black bean seed coats, characterised by a HPLC system with a UV-visible detector and an evaporative light-scattering detector and HPLC-time-of-flight/MS, contained quercetin 3-O-glucoside and soyasaponin Af as the primary flavonoid and saponin, respectively. The extract significantly reduced the expression of SREBP1c, FAS and HMGCR, and stimulated the expression of the reverse cholesterol transporters ABCG5/ABCG8 and CYP7A1 in the liver. In addition, there was an increase in the expression of hepatic PPAR-α. Consequently, there was a decrease in hepatic lipid depots and a significant increase in bile acid secretion. Furthermore, the ingestion of this extract modulated the proportion of lipids that was used as a substrate for energy generation. Thus, the results suggest that the extract of black bean seed coats may decrease hepatic lipogenesis and stimulate cholesterol excretion, in part, via bile acid synthesis.


Subject(s)
Cholagogues and Choleretics/therapeutic use , Dietary Supplements , Flavonoids/therapeutic use , Lipotropic Agents/therapeutic use , Phaseolus/chemistry , Saponins/therapeutic use , Seeds/chemistry , Animals , Bile Acids and Salts/metabolism , Cells, Cultured , Cholagogues and Choleretics/chemistry , Cholagogues and Choleretics/isolation & purification , Cholagogues and Choleretics/metabolism , Cholesterol/metabolism , Flavonoids/chemistry , Flavonoids/isolation & purification , Flavonoids/metabolism , Gene Expression Regulation , Hepatocytes/cytology , Hepatocytes/enzymology , Hepatocytes/metabolism , Lipid Metabolism , Lipotropic Agents/chemistry , Lipotropic Agents/isolation & purification , Lipotropic Agents/metabolism , Liver X Receptors , Male , Mexico , Mice , Mice, Inbred C57BL , Orphan Nuclear Receptors/agonists , Orphan Nuclear Receptors/genetics , Orphan Nuclear Receptors/metabolism , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Extracts/metabolism , Plant Extracts/therapeutic use , Random Allocation , Rats , Saponins/chemistry , Saponins/isolation & purification , Saponins/metabolism
3.
Eksp Klin Gastroenterol ; (10): 59-63, 2014.
Article in Russian | MEDLINE | ID: mdl-25911933

ABSTRACT

The choleretic and hepatoprotective effect of Hypecoum erectum L. dry extract on toxic hepatitis was studied. Experimental hepatitis was caused by the introduction of D-galactosamine to Wistar white rats in the dose of 500 mg/kg of the animal weight once a day for 3 days. The H. erectum extract was administered per os in the dose of 50 mg/kg for 7 days. It has been established that H. erectum extract has a marked hepatoprotective effect in the case of D-galactosamine hepatitis in white rats that is characterized by inhibition of the disturbances in cholate-synthetic functions of the liver, increase of bile secretion rate, preservation of cholate concentration in the bile. The tested remedy diminishes dystrophic and necrotic processes, decreases the intensity of inflammatory infiltration in the liver and stimulates regeneration of liver cells in D-galactosamine hepatitis.


Subject(s)
Chemical and Drug Induced Liver Injury/drug therapy , Cholagogues and Choleretics/therapeutic use , Papaveraceae/chemistry , Plant Extracts/therapeutic use , Animals , Bile/chemistry , Bile/metabolism , Bile Acids and Salts/analysis , Bilirubin/analysis , Chemical and Drug Induced Liver Injury/metabolism , Chemical and Drug Induced Liver Injury/pathology , Cholagogues and Choleretics/administration & dosage , Cholagogues and Choleretics/isolation & purification , Cholesterol/analysis , Dose-Response Relationship, Drug , Female , Male , Plant Extracts/administration & dosage , Plant Extracts/isolation & purification , Rats, Wistar , Time Factors
4.
Exp Toxicol Pathol ; 65(6): 837-44, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23298556

ABSTRACT

Artemisia capillaris has been widely used as a traditional herbal medicine in the treatment of liver diseases. However, no previous study has investigated whether A. capillaries alone is effective in treating pathological conditions associated with cholestatic liver injury. In the present study, we evaluated the anti-hepatofibrotic effects of A. capillaris (aqueous extract, WAC) in a bile duct ligation (BDL)-induced cholestatic fibrosis model. After BDL, rats were given WAC (25 or 50 mg/kg) or urosodeoxycholic acid (UDCA, 25 mg/kg) orally for 2 weeks (once per day). The serum cholestatic markers, malondialdehyde, and liver hydroxyproline levels were drastically increased in the BDL group, while administering WAC significantly reduced these alterations. Administering WAC also restored the BDL-induced depletion of glutathione content and glutathione peroxidase activity. Cholestatic liver injury and collagen deposition were markedly attenuated by WAC treatment, and these changes were paralleled by the significantly suppressed expression of fibrogenic factors, including hepatic alpha-smooth muscle actin (α-SMA), platelet-derived growth factor (PDGF), and transforming growth factor beta (TGF-ß). The beneficial effects of WAC administration are associated with antifibrotic properties via both upregulation of antioxidant activities and downregulation of ECM protein production in the rat BDL model.


Subject(s)
Artemisia/chemistry , Cholagogues and Choleretics/therapeutic use , Cholestasis/complications , Drugs, Chinese Herbal/therapeutic use , Liver Cirrhosis/prevention & control , Animals , Antioxidants/metabolism , Cholagogues and Choleretics/administration & dosage , Cholagogues and Choleretics/isolation & purification , Cholestasis/pathology , Disease Models, Animal , Dose-Response Relationship, Drug , Drugs, Chinese Herbal/administration & dosage , Drugs, Chinese Herbal/isolation & purification , Liver Cirrhosis/etiology , Liver Cirrhosis/pathology , Liver Function Tests , Male , Rats , Rats, Sprague-Dawley , Ursodeoxycholic Acid/administration & dosage , Ursodeoxycholic Acid/therapeutic use
5.
Pak J Biol Sci ; 12(13): 949-56, 2009 Jul 01.
Article in English | MEDLINE | ID: mdl-19817121

ABSTRACT

Gardenia jasminoides E. (Rubiaceae) methanol extracts showed the highest level of antifungal activity against Pleurotus ostreatus, a wood-rotting fungus, compared to five other methanol plants extracts; [Thuja orientalis L. (Cupressaceae), Datura innoxia (Solanaceae), Ligustrum japonicum T. (Oleaceae), Juniperus chinensis var. procumbens (Cupressaceae) and Mallotus japonica M. (Euphorbiaceae)] and selected for further analysis. Two antifungal compounds were isolated from n-butanol and ethyl acetate solubles in the methanol extracts of Gardenia jasminoides leaves and stems by bioassay-guided fractionation, using Pleurotus ostreatus. The antifungal compounds found for the first time in Gardenia jasminoides against Pleurotus ostreatus were identified as genipin and geniposide based on instrumental analyses. Both also had potent inhibitory effects on two plant pathogenic fungi; Fusarium oxysporum and Corynespora cassiicola.


Subject(s)
Antifungal Agents , Fungi/drug effects , Gardenia/chemistry , Iridoids , Plant Extracts , Antifungal Agents/chemistry , Antifungal Agents/isolation & purification , Antifungal Agents/pharmacology , Cholagogues and Choleretics/chemistry , Cholagogues and Choleretics/isolation & purification , Cholagogues and Choleretics/pharmacology , Iridoid Glycosides , Iridoids/chemistry , Iridoids/isolation & purification , Iridoids/pharmacology , Microbial Sensitivity Tests , Molecular Structure , Plant Extracts/chemistry , Plant Extracts/pharmacology
9.
Planta Med ; 55(2): 127-32, 1989 Apr.
Article in English | MEDLINE | ID: mdl-2748727

ABSTRACT

According to our results, the traditional therapeutic indications of Eupatorium cannabinum L., choleretic and hepatoprotective effects, have been widely demonstrated. An aqueous extract induces hypercholeresis in the rat, the site of bile formation is canalicular in origin and both bile acid-dependent and bile acid-independent flows could be stimulated; the extract possesses anti-necrotic properties against carbon tetrachloride-induced hepatotoxicity, reducing widely the plasma GPT level in pretreated rats.


Subject(s)
Cholagogues and Choleretics , Hepatitis, Animal/drug therapy , Plant Extracts/pharmacology , Animals , Bile Acids and Salts/metabolism , Cholagogues and Choleretics/isolation & purification , Erythritol/metabolism , Male , Medicine, Traditional , Rats , Rats, Inbred Strains
10.
J Pharmacobiodyn ; 6(5): 281-6, 1983 May.
Article in English | MEDLINE | ID: mdl-6620117

ABSTRACT

The present study was carried out to elucidate the effect of clove and its active principles in view of cholagogue. The cholagogue effect was observed in acetone extract of clove and eugenol. Acetyl-eugenol also possessed cholagogue property.


Subject(s)
Cholagogues and Choleretics/isolation & purification , Condiments/analysis , Plant Extracts/pharmacology , Animals , Bile/metabolism , Bile Acids and Salts/metabolism , Chemistry, Pharmaceutical , Cholagogues and Choleretics/pharmacology , Cholesterol/metabolism , Male , Phospholipids/metabolism , Rats , Rats, Inbred Strains , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...